17.74

5.03% 0.85

After Hours: 17.74

Pulse Biosciences Inc (PLSE)

Overview News Price History Option Chain Financials Discussions Forecast

Pulse Biosciences Inc stock is traded at $17.74, with a volume of 132.20K. It is up +5.03% in the last 24 hours and up +10.53% over the past month. Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

Previous Close:

$16.89

Open:

$16.9

24h Volume:

132.20K

Relative Volume:

0.74

Market Cap:

$1.11B

Revenue:

Net Income/Loss:

$-46.13M

P/E Ratio:

-21.84

EPS:

-0.8123

Net Cash Flow:

$-34.10M

1W Performance:

+14.01%

1M Performance:

+10.53%

6M Performance:

-0.17%

1Y Performance:

+137.48%

1-Day Range:

$16.71

$18.17

1-Week Range:

$15.49

$18.17

52-Week Range:

$6.595

$25.00

Pulse Biosciences Inc Stock (PLSE) Company Profile

Name

Pulse Biosciences Inc

Sector

Healthcare (1151)

Industry

Medical Instruments & Supplies (63)

Phone

510-906-4600

Address

3957 POINT EDEN WAY, HAYWARD, CA

Employee

Twitter

@PulseBioNPS

Next Earnings Date

2024-10-30

Latest SEC Filings

PLSE's Discussions on Twitter

Compare PLSE with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PLSE Pulse Biosciences Inc	17.74	1.11B	0	-46.13M	-34.10M	-0.8123
ISRG Intuitive Surgical Inc	482.74	175.60B	8.35B	2.32B	1.30B	6.41
BDX Becton Dickinson Co	198.71	59.07B	20.64B	1.73B	2.94B	6.02
ALC Alcon Inc	92.54	44.80B	9.91B	1.02B	665.00M	2.05
RMD Resmed Inc	212.91	31.51B	4.93B	1.25B	1.38B	8.47
COO The Cooper Companies, Inc.	79.51	15.75B	3.90B	392.30M	288.10M	1.95

Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-27-21	Initiated	Stephens	Overweight
Mar-11-21	Initiated	Maxim Group	Buy
Jan-26-21	Reiterated	H.C. Wainwright	Buy
May-12-20	Upgrade	H.C. Wainwright	Neutral → Buy
Feb-14-20	Downgrade	H.C. Wainwright	Buy → Neutral
Feb-25-19	Initiated	H.C. Wainwright	Buy

View All

Pulse Biosciences Inc Stock (PLSE) Latest News

Apr 17, 2025

Vanguard Group Inc. Purchases 150,506 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World

Apr 17, 2025

Apr 14, 2025

Corebridge Financial Inc. Cuts Stake in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World

Apr 14, 2025

Apr 13, 2025

20,000 Shares in Pulse Biosciences, Inc. (NASDAQ:PLSE) Bought by Norges Bank - Defense World

Apr 13, 2025

KLP Kapitalforvaltning AS Buys Shares of 2,500 Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World

Apr 13, 2025

Apr 10, 2025

Pulse Biosciences: Some Key Questions Remain Unanswered - Seeking Alpha

Apr 10, 2025

Pulse Biosciences at Needham Conference: Strategic Growth and Market Expansion - Investing.com UK

Apr 10, 2025

Pulse Biosciences: Interesting Product, But No Revenue Stream (NASDAQ:PLSE) - Seeking Alpha

Apr 10, 2025

Apr 06, 2025

When (PLSE) Moves Investors should Listen - news.stocktradersdaily.com

Apr 06, 2025

Apr 05, 2025

INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm - ACCESS Newswire

Apr 05, 2025

Apr 03, 2025

Pulse Biosciences, Inc. Announces Closing of $30 Million Rights Offering - Business Wire

Apr 03, 2025

Apr 01, 2025

Pulse Biosciences (NASDAQ:PLSE) Upgraded to Sell at StockNews.com - Defense World

Apr 01, 2025

Mar 31, 2025

Pulse Biosciences Reports Business Updates and Third Quarter 2024 Financial Results - TradingView

Mar 28, 2025

Charles Schwab Investment Management Inc. Grows Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World

Mar 28, 2025